Lead party: Edge Growth Ventures Proprietary Limited (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Rand Pharm
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: Vumela 3.0 – Vumela Enterprise Development Fund
Investors/buyers: Edge Growth Ventures Proprietary Limited
Legal advisers: not identified in the source record.
Source: announced 27 May 2021. Original announcement: africaglobalfunds.com.


